Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe LONDON, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Aimmune Therapeutics, Inc., a Nestlé Health Science Company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...